Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Cited In for PubMed (Select 12424195)

1.

Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.

Chopra M, Brandl A, Siegmund D, Mottok A, Schäfer V, Biehl M, Kraus S, Bäuerlein CA, Ritz M, Mattenheimer K, Schwinn S, Seher A, Grabinger T, Einsele H, Rosenwald A, Brunner T, Beilhack A, Wajant H.

Blood. 2015 Jul 23;126(4):437-44. doi: 10.1182/blood-2015-01-620583. Epub 2015 May 26.

2.

A PROGNOSTIC SCORE FOR ACUTE GRAFT-VERSUS-HOST DISEASE BASED ON BIOMARKERS: A MULTICENTER STUDY.

Levine JE, Braun TM, Harris AC, Holler E, Taylor A, Miller H, Magenau J, Weisdorf DJ, Ho VT, Bolaños-Meade J, Alousi AM, Ferrara LM; for the Blood and Marrow Transplant Clinical Trials Network.

Lancet Haematol. 2015 Jan 1;2(1):e21-e29.

PMID:
25729761
3.

Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity.

Fowler BJ, Gelfand BD, Kim Y, Kerur N, Tarallo V, Hirano Y, Amarnath S, Fowler DH, Radwan M, Young MT, Pittman K, Kubes P, Agarwal HK, Parang K, Hinton DR, Bastos-Carvalho A, Li S, Yasuma T, Mizutani T, Yasuma R, Wright C, Ambati J.

Science. 2014 Nov 21;346(6212):1000-3. doi: 10.1126/science.1261754.

4.

The biology of graft-versus-host disease: experimental systems instructing clinical practice.

Markey KA, MacDonald KP, Hill GR.

Blood. 2014 Jul 17;124(3):354-62. doi: 10.1182/blood-2014-02-514745. Epub 2014 Jun 9. Review.

5.

Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.

Aoyama K, Saha A, Tolar J, Riddle MJ, Veenstra RG, Taylor PA, Blomhoff R, Panoskaltsis-Mortari A, Klebanoff CA, Socié G, Munn DH, Murphy WJ, Serody JS, Fulton LM, Teshima T, Chandraratna RA, Dmitrovsky E, Guo Y, Noelle RJ, Blazar BR.

Blood. 2013 Sep 19;122(12):2125-34. doi: 10.1182/blood-2012-11-470252. Epub 2013 Jun 27.

6.

Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.

Young JS, Wu T, Chen Y, Zhao D, Liu H, Yi T, Johnston H, Racine J, Li X, Wang A, Todorov I, Zeng D.

J Immunol. 2012 Jul 1;189(1):222-33. doi: 10.4049/jimmunol.1200677. Epub 2012 May 30.

7.

Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.

Hanash AM, Kappel LW, Yim NL, Nejat RA, Goldberg GL, Smith OM, Rao UK, Dykstra L, Na IK, Holland AM, Dudakov JA, Liu C, Murphy GF, Leonard WJ, Heller G, van den Brink MR.

Blood. 2011 Jul 14;118(2):446-55. doi: 10.1182/blood-2010-07-294785. Epub 2011 May 19.

8.

Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and Trimidox.

Inayat MS, El-Amouri IS, Bani-Ahmad M, Elford HL, Gallicchio VS, Oakley OR.

J Inflamm (Lond). 2010 Aug 18;7:43. doi: 10.1186/1476-9255-7-43.

9.

Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease.

Oh I, Ozaki K, Meguro A, Hatanaka K, Kadowaki M, Matsu H, Tatara R, Sato K, Iwakura Y, Nakae S, Sudo K, Teshima T, Leonard WJ, Ozawa K.

J Immunol. 2010 Aug 1;185(3):1920-6. doi: 10.4049/jimmunol.0902217. Epub 2010 Jun 23.

10.

Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease.

Burnier L, Saller F, Kadi L, Brisset AC, Sugamele R, Baudino L, Bono F, Herbert JM, Carmeliet P, Schapira M, Izui S, Angelillo-Scherrer A.

Blood. 2010 Apr 22;115(16):3390-7. doi: 10.1182/blood-2009-02-206920. Epub 2010 Feb 4.

11.

The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Na IK, Lu SX, Yim NL, Goldberg GL, Tsai J, Rao U, Smith OM, King CG, Suh D, Hirschhorn-Cymerman D, Palomba L, Penack O, Holland AM, Jenq RR, Ghosh A, Tran H, Merghoub T, Liu C, Sempowski GD, Ventevogel M, Beauchemin N, van den Brink MR.

J Clin Invest. 2010 Jan;120(1):343-56. doi: 10.1172/JCI39395. Epub 2009 Dec 1.

12.

A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.

Couriel DR, Saliba R, de Lima M, Giralt S, Andersson B, Khouri I, Hosing C, Ippoliti C, Shpall EJ, Champlin R, Alousi A.

Biol Blood Marrow Transplant. 2009 Dec;15(12):1555-62. doi: 10.1016/j.bbmt.2009.08.003. Epub 2009 Sep 25.

13.

Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review.

Koreth J, Alyea EP, Murphy WJ, Welniak LA.

Biol Blood Marrow Transplant. 2009 Dec;15(12):1502-12. doi: 10.1016/j.bbmt.2009.07.016. Review.

14.

Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease.

Rotolo JA, Stancevic B, Lu SX, Zhang J, Suh D, King CG, Kappel LW, Murphy GF, Liu C, Fuks Z, van den Brink MR, Kolesnick R.

Blood. 2009 Oct 22;114(17):3693-706. doi: 10.1182/blood-2008-11-191148. Epub 2009 Aug 7.

15.
16.

Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.

Das R, Chen X, Komorowski R, Hessner MJ, Drobyski WR.

Blood. 2009 Mar 5;113(10):2352-62. doi: 10.1182/blood-2008-08-175448. Epub 2008 Dec 4.

17.

Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.

Kitko CL, Paczesny S, Yanik G, Braun T, Jones D, Whitfield J, Choi SW, Hutchinson RJ, Ferrara JL, Levine JE.

Biol Blood Marrow Transplant. 2008 Jul;14(7):759-65. doi: 10.1016/j.bbmt.2008.04.002.

18.

Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation.

Sun K, Li M, Sayers TJ, Welniak LA, Murphy WJ.

Blood. 2008 Aug 15;112(4):1522-9. doi: 10.1182/blood-2008-03-143461. Epub 2008 Jun 6.

19.

A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome.

Hildebrandt GC, Olkiewicz KM, Corrion L, Clouthier SG, Pierce EM, Liu C, Cooke KR.

Biol Blood Marrow Transplant. 2008 Apr;14(4):385-96. doi: 10.1016/j.bbmt.2008.01.004.

20.

Acute graft versus host disease.

Jacobsohn DA, Vogelsang GB.

Orphanet J Rare Dis. 2007 Sep 4;2:35. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk